Table 1.

Clinicopathologic features of patients

CharacteristicAutopsy patients (n = 79)
Age at diagnosis, years (mean ± SD)62.2 ± 11.4
Gender (%)
 Male44 (56%)
 Female35 (44%)
Tumor location (%)
 Head/body64 (81%)
 Tail14 (18%)
 NA1 (1%)
Stage at diagnosis (%)
 I/II20 (26%)
 III19 (24%)
 IV40 (50%)
Tumor differentiation (%)
 Well/moderate27 (34%)
 Poor52 (66%)
Treatment (%)
 Chemoradiation32 (41%)
 Chemotherapy34 (43%)
 None13 (16%)
Median overall survival, months (range)10 (0.75–58)
Major sites involved by metastatic disease at autopsya (%)
 Liver (n = 79)60 (76%)
 Lung (n = 65)b31 (48%)
 Peritoneum (n = 69)c41 (59%)
Number of sites involved by metastatic disease (%)b,c
 08 (10%)
 126 (33%)
 229 (37%)
 ≥316 (20%)
Metastatic burden (%)
 0–10 (oligometastatic)22 (28%)
 11–100 (moderate)27 (34%)
 >100 (widely metastatic)29 (37%)
  • Abbreviation: NA, not available.

  • aRefers to frequency at each site independently.

  • bData regarding presence of lung metastasis not available for 14 patients.

  • cData regarding presence of peritoneal metastasis not available for 10 patients.